Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
Clinical trial NCT01710709 · COMPLETED
Trial details
- NCT number
- NCT01710709
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 748
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.